Scientists across Norwich Research Park institutes are part of a major integrated UK research-industry programme led by The Alan Turing Institute, seeking out the best talent in AI and data science, developing bioscience leaders and supporting the UK economy.
Coulter Partners was very pleased to partner recently with OxSonics® Therapeutics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer, to secure the appointment of Dr Allison Jeynes as non-executive Chair of the Board of Directors.
The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the placement of Sharon Curran as a new independent Non-Executive Director at Clinigen Group, a global, specialist pharmaceutical services and products platform focused on providing ethical access to medicines.
Leading pharmaceutical and biotech product development consultancy, Boyds has announced the appointment of Neil Chakrabarti as Chief Financial Officer.
The appointment comes as the company reported a record-breaking 25 percent growth in turnover as demand for its specialist services continues to grow.
Medannex Ltd (Edinburgh) this week received multiple awards in recognition of notable successes in
several key areas. The late-stage biopharmaceutical company, developing novel treatments for cancers
and autoimmune diseases, was declared the winner in all three categories in which it was nominated at
Scotland’s Life Sciences Annual Awards.
Babraham Bioscience Technologies Ltd (BBT), the organisation which oversees the development and day-to-day management of the Babraham Research Campus is delighted to confirm Jo Parfrey as the new BBT Board Chair.
A new survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation.
Coulter Partners was delighted to partner again recently with Optimapharm to secure the appointments of Walter Miller as Chief Finance Officer and Dr Charles Woler, M.D., Ph.D., as Non-Executive Director. Optimapharm is a contract research organization (CRO) managing clinical trials on behalf of leading biotech, pharma and medical devices companies in 27 countries across EMEA.
Global Life Sciences executive search specialist, Coulter Partners is delighted to announce continuing growth across the company in 2021. The London team expands with new Associates, Lucy Webb and Ana Delgado, Research Analysts, Jacob Taylor and Liam Fryer, and Director, Carina McEntire. In the US, Ayn Teigman joins as Associate and Irlanda Almendarez as Senior Research Associate. In Frankfurt, the team is strengthened with Sonia Keim, Associate and Katja Färber, Senior Research Associate.